Introduction CMC documentation at a CDMO for ANDA submissions forms the foundation of regulatory compliance by demonstrating that a generic […]
CMC Documentation at a CDMO for ANDA: What Goes Into Sections P and S of the CTD Read More »
Introduction Intact Mass Analysis and Average Mass Determination are fundamental techniques used to confirm the primary structure of complex multi-chain
Introduction Forced Degradation and Photostability Studies for Generic Drug ANDA Submissions form the analytical cornerstone required to demonstrate that a
Forced Degradation and Photostability Studies for Generic Drug ANDA Submissions Read More »
Introduction Radiolabeled Peptide Manufacturing involves a highly coordinated framework that combines automated solid-phase peptide synthesis, efficient chelator conjugation, and controlled
Case Study: Radiolabeled Peptide Manufacturing for a Diagnostic Imaging Program Read More »
Introduction Container Closure Integrity Testing (CCIT) for Generic Sterile Drug Products is a critical process used to confirm that a
Introduction CDMO Services for Generic Topical and Semisolid Drug Products provide the specialized formulation development, analytical characterization, and manufacturing capabilities
Introduction Bioequivalence study design for complex generic drug products requires a comprehensive and integrated development strategy that combines precise qualitative/quantitative
Introduction Outsourcing Extractables and Leachables (E&L) Testing to a Drug Establishment License (DEL) holder ensures that analytical data is generated
Introduction Formulating a Lyophilized Peptide Injectable involves the strategic design of a solid-state glass matrix capable of maintaining peptide chemical
Introduction Establishing analytical similarity is a fundamental requirement for obtaining regulatory approval of biosimilar therapeutic proteins. A comprehensive Biosimilar Comparability
